How Will Public Offering Pricing Affect Avanir Pharmaceuticals (AVNR) Stock Today?

NEW YORK (TheStreet) -- Shares of Avanir Pharmaceuticals  (AVNR) rose 2.92% to $11.64 in morning trading Wednesday after the company priced its public offering of common stock.

Avanir priced 18.2 million shares at $11 a share. The offering, which Avanir expects to close on or around September 29, contains a 30-day option for underwriters to purchase up to an addition 2.73 million shares.

The company expects gross proceeds of $200.2 million from the offering. Avanir plans to use net proceeds to help fund NUEDEXTA commercial activities and the commercial launch of AVP-825 and for other general corporate purposes.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

More than 6.7 million shares had changed hands as of 10:07 a.m., compared to the average volume of 4,523,190.

AVNR Chart AVNR data by YCharts

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

More from Markets

Global Stocks Edge Higher, But Bond Yields, Oil Prices May Test Market Strength

Global Stocks Edge Higher, But Bond Yields, Oil Prices May Test Market Strength

Sohn Conference Briefly Distracts From Barrage of Earnings -- ICYMI

Sohn Conference Briefly Distracts From Barrage of Earnings -- ICYMI

Dow and Nasdaq Finish Lower as 10-Year Treasury Yield Hovers Near 3%

Dow and Nasdaq Finish Lower as 10-Year Treasury Yield Hovers Near 3%

Video: Stop Using Student Loan Money to Buy Bitcoin

Video: Stop Using Student Loan Money to Buy Bitcoin

Let the Najarian Brothers Crash-Proof Portfolio

Let the Najarian Brothers Crash-Proof Portfolio